Stock AASTROM BIOSCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Aastrom Biosciences Inc Nasdaq

Equities

US00253U3059

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Aastrom Biosciences Inc
19/04 Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing MT
15/03 Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing MT

Chart calendar Aastrom Biosciences Inc

f557447c4983e647d38165cd7f299187.3x_pEF8X0ujBTQ-JrqWtVUruHIaH9vAUfLCQT0mAra0.lGndenJyv7GeGz3txe3PIQO6bPHwt5RmLeKgegyyxJW9SqhyCniYnqR4eA~ed7eb5da17e3e7beba96ea1177563798

Upcoming events on Aastrom Biosciences Inc

08/05/2024 05:25 pm Q1 2024 Earnings Release
08/05/2024 06:00 pm Q1 2024 Earnings Call
31/07/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Aastrom Biosciences Inc

01/05/2024 06:30 pm Annual General Meeting
05/03/2024 09:40 pm TD Cowen Health Care Conference
29/02/2024 07:00 pm Q4 2023 Earnings Call
29/02/2024 06:25 pm Q4 2023 Earnings Release
12/02/2024 09:30 pm Canaccord Genuity Musculoskeletal Conference
10/01/2024 09:00 pm JPMorgan Healthcare Conference
15/11/2023 08:30 pm Stephens Investment Conference
08/11/2023 07:00 pm Q3 2023 Earnings Call
08/11/2023 06:25 pm Q3 2023 Earnings Release
12/09/2023 05:00 pm Morgan Stanley Global Healthcare Conference
02/08/2023 06:00 pm Q2 2023 Earnings Call
02/08/2023 05:25 pm Q2 2023 Earnings Release
10/05/2023 06:00 pm Q1 2023 Earnings Call
10/05/2023 05:25 pm Q1 2023 Earnings Release
03/05/2023 06:30 pm Annual General Meeting
07/03/2023 11:00 pm Canaccord Genuity Musculoskeletal Conference
23/02/2023 07:00 pm FY 2022 Earnings Call
23/02/2023 06:25 pm FY 2022 Earnings Release
11/01/2023 09:00 pm JP Morgan Healthcare Conference
17/11/2022 09:30 pm Stephens Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		118
117
0.35%		124
124
0.17%		156
157
-0.32%		164
165
-0.16%		198
197
0.01%
239

EBITDA
Million USD		Released
Forecast
Spread 		-9,51
-10,5
9.46%		18,6
16,7
10.99%		29,5
32,0
-7.86%		24,2
22,6
6.9%		33,9
30,7
10.29%
48,5

EBIT
Million USD		Released
Forecast
Spread 		-11,3
-11,5
2.23%		2,37
0,04
6354.42%		-7,85
-5,61
-39.94%		-17,1
-21,4
20.3%		-6,46
-10,2
36.88%
5,36

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,67
-10,3
5.89%		3,04
1,05
190.64%		-7,58
-4,23
-79.37%		-16,0
-20,8
23.27%		-2,37
-7,32
67.65%
6,72

Net income
Million USD		Released
Forecast
Spread 		-9,67
-10,4
6.9%		2,86
0,49
479.46%		-7,47
-5,39
-38.6%		-16,7
-20,9
20.12%		-3,18
-7,63
58.28%
4,27

EPS
USD		Released
Forecast
Spread 		-0,22
-0,23
5.04%		0,06
0,01
700%		-0,16
-0,12
-37.93%		-0,35
-0,44
21.17%		-0,07
-0,16
56.25%
0,08

Announcement Date25/02/2024/02/2124/02/2223/02/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		47,6
48,1
-1.03%		36,1
34,3
5.16%		37,0
38,3
-3.39%		38,6
39,9
-3.38%		52,7
53,0
-0.5%		41,0
37,4
9.76%		45,9
42,1
9%		45,6
45,1
0.96%		65,0
65,0
0.03%
49,1


54,3


57,0


78,8


60,3

EBITDA
Million USD		Released
Forecast
Spread 		12,8
15,3
-16.54%		3,24
4,14
-21.71%		2,77
5,20
-46.7%		3,33
6,08
-45.32%		14,9
13,4
10.85%		1,70
4,72
-63.96%		4,44
2,52
76.11%		5,44
4,31
26.25%		22,3
19,1
16.56%
4,74


7,17


8,49


28,1


11,2

EBIT
Million USD		Released
Forecast
Spread 		4,14
6,39
-35.15%		-7,27
-4,55
-59.84%		-9,08
-5,95
-52.59%		-6,79
-4,91
-38.37%		6,09
1,74
249.15%		-8,18
-7,51
-8.87%		-5,96
-7,36
19.04%		-5,06
-6,15
17.71%		12,7
9,00
41.42%
-5,49


-2,68


-1,49


15,0


-0,25

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		4,21
7,57
-44.38%		-7,09
-4,21
-68.31%		-8,96
-5,87
-52.76%		-6,56
-4,73
-38.69%		6,62
1,77
274%		-7,50
-7,41
-1.09%		-5,02
-7,75
35.2%		-3,95
-5,99
34.12%		14,1
9,20
53.25%
-5,17


-2,33


-1,14


15,4


0,09

Net income
Million USD		Released
Forecast
Spread 		4,54
6,60
-31.24%		-7,09
-3,79
-86.99%		-8,96
-5,79
-54.89%		-6,58
-4,84
-35.96%		5,92
1,72
244.18%		-7,50
-7,41
-1.09%		-5,02
-7,29
31.1%		-3,66
-5,75
36.38%		13,0
8,59
51.3%
-5,33


-2,65


-1,07


13,3


-0,08

EPS
USD		Released
Forecast
Spread 		0,09
0,14
-34.78%		-0,15
-0,12
-28.57%		-0,19
-0,12
-55.74%		-0,14
-0,10
-37.25%		0,13
0,04
261.11%		-0,16
-0,15
-4.35%		-0,11
-0,15
27.63%		-0,08
-0,12
34.25%		0,26
0,17
54.76%
-0,11


-0,06


-0,02


0,26


-0,03

Announcement Date24/02/2204/05/2203/08/2209/11/2223/02/2310/05/2302/08/2308/11/2329/02/24-----

Upcoming sector events for Aastrom Biosciences Inc

Today 04:30 pm AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release
07/05/2024 BIOTEST AG: Q1 2024 Earnings Release
07/05/2024 AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024 APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 11:30 am BIOGAIA AB: Q1 2024 Earnings Release
07/05/2024 05:00 pm INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release
08/05/2024 CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
08/05/2024 ZAI LAB LIMITED: Q1 2024 Earnings Release
08/05/2024 05:25 pm VERICEL CORPORATION: Q1 2024 Earnings Release
09/05/2024 NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
More events

Past sector events for Aastrom Biosciences Inc

03/05/2024 01:35 am TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release
02/05/2024 05:20 pm ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release
02/05/2024 05:00 pm BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release
02/05/2024 SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release
30/04/2024 04:30 pm INCYTE CORPORATION: Q1 2024 Earnings Release
30/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
30/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
30/04/2024 03:23 am SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release
29/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. VCEL Stock
  4. Stock
  5. Calendar Aastrom Biosciences Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW